Skip to main content

Animations

MJFF Publications

4381 - 4390 of 9117 Results
Title
Year
  • Year
  • 2013
  • 2022
  • 2024
  • 2018
  • 2026
  • 2020
  • 2010
  • 2025
  • 2025
  • 2019
  • Summary Details
    OPEN
    Title: Persistent activation of the D1R/Shp-2/Erk1/2 pathway in l-DOPA-induced dyskinesia in the 6-hydroxy-dopamine rat model of Parkinson's disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2013.01.005
    Citation Count: 41
  • Summary Details
    OPEN
    Title: Level I PD‐MCI Using Global Cognitive Tests and the Risk for Parkinson's Disease Dementia
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mdc3.13451
    Citation Count: 29
  • Summary Details
    OPEN
    Title: Role of alpha-synuclein seed amplification assay in Parkinson’s disease clinical trials: A case of misdiagnosis
    Journal Name: Clinical Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.prdoa.2024.100274
    Citation Count: 2
  • Summary Details
    OPEN
    Title: USP 14 inhibition corrects an in vivo model of impaired mitophagy
    Journal Name: EMBO Molecular Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.15252/emmm.201809014
    Citation Count: 118
  • Summary Details
    OPEN
    Title: A cross-sectional exploration of the relationship between Parkinson's disease and peripheral blood immune cells in an ethnically diverse East London population
    Journal Name: Journal of the Neurological Sciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.jns.2026.125785
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Human plasma biomarker responses to inhalational general anaesthesia without surgery
    Journal Name: British Journal of Anaesthesia
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bja.2020.04.085
    Citation Count: 54
  • Summary Details
    OPEN
    Title: Effects of intrastriatal GDNF on the response of dopamine neurons to 6-hydroxydopamine: Time course of protection and neurorestoration
    Journal Name: Brain Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.brainres.2010.11.006
    Citation Count: 41
  • Summary Details
    OPEN
    Title: Free water predicts dementia with Lewy bodies in isolated REM sleep behavior disorder
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/alz.70570
    Citation Count: 3
  • Summary Details
    OPEN
    Title: The Genetic Landscape of Hereditary Spastic Paraplegia in Greece
    Journal Name: Clinical Genetics
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1111/cge.70113
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30141-3
    Citation Count: 126
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.